Flanca Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 2 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Flanca Life Sciences
Flanca Life Sciences Private Limited (FLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 December 2022 (Two years and one month 0 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ravneet Singh, Harsimran Kalra, Jitender Kalra, and Two other members serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51909CH2022PTC044768
- Company No.
044768
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Flanca Life Sciences?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravneet Singh  | Director | 30-Dec-2022 | Current |
| Harsimran Kalra | Director | 30-Dec-2022 | Current |
| Jitender Kalra | Director | 30-Dec-2022 | Current |
| Pavneet Kalra | Director | 30-Dec-2022 | Current |
| Mandeep Kalra | Director | 30-Dec-2022 | Current |
Financial Performance of Flanca Life Sciences.
Enhance accessibility to Flanca Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Flanca Life Sciences?
Unlock access to Flanca Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Systole Remedies Private LimitedRavneet Singh, Harsimran Kalra and 3 more are mutual person
Janus Biotech India Private LimitedRavneet Singh, Harsimran Kalra and 1 more are mutual person
Burgeon Health Series Private LimitedRavneet Singh, Harsimran Kalra and 1 more are mutual person
Nyx Pharmaceuticals Private LimitedRavneet Singh, Harsimran Kalra and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Flanca Life Sciences?
Flanca Life Sciences has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Flanca Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Flanca Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.